[Sclerosing therapy of esophageal varicosis (author's transl)].
As long-term results of portosystemic shunt operations for decompression of the portal hypertension are unsatisfactory, the author's therapeutic trials are directed increasingly at local treatment of varicosity. One treatment used is esophagoscopic submucosal sclerosing therapy of the esophageal wall for detachment of the varices from the surface. This method proved to be of great value in 420 patients, as the incidence of fatal recurrences of bleeding was only 12% and primary mortality was 15%. Suggested indications for endoscopic mural sclerosing are discussed. Mural sclerosing associated with transhepatic percutaneous esophageal varix sclerosis (following Lunderquist) might improve the results further in some cases.
D000328:Adult; D002648:Child; D004932:Esophageal and Gastric Varices / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D004945:Esophagoscopy; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D006801:Humans; D006975:Hypertension, Portal / Q000628:therapy; D010166:Palliative Care; D012008:Recurrence; D012597:Sclerosing Solutions / Q000627:therapeutic use*
D012597:Sclerosing Solutions
17. Sklerosierung der Oesophagusvaricen